References
Nakamura S, Matsumoto T. Gastrointestinal lymphoma: recent advances in diagnosis and treatment. Digestion. 2013;87:182–8.
Nakamura S, Matsumoto T, Iida M, Yao T, Tsuneyoshi M. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462–73.
Ferreri A, Montalbán C. Primary diffuse large B-cell lymphoma of the stomach. Crit Rev Oncol Hematol. 2007;63:65–71.
Nakamura S, Akazawa K, Yao T, Tsuneyoshi M. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 index. Cancer. 1995;76:1313–24.
Sakae H, Tamai T, Oda K, Suzuki S, Hiraki T, Taniyama O, et al. Malignant lymphoma with splenic rupture presenting as acute hepatic failure. Kanzo. 2016;57:674–83.
Stein H, Warnke RA, Chan WC, et al. Diffuse large B-cell lymphoma, not otherwise specified. WHO Classification of Tumours of Heamatopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer; 2008. p. 233–7.
Mori M, Kitamura K, Masuda M, Hotta T, Miyazaki T, Miura AB, et al. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin’s lymphoma. Int J Hematol. 2005;81:246–54.
Denkert C, Loibl S, Muller BM, Eidtmann H, Schmitt WD, Eiermann W, et al. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Ann Oncol. 2013;24:2786–93.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Goto, A., Nishikawa, J., Ito, S. et al. A Rapidly Developing Diffuse Large B cell Lymphoma of the Stomach. J Gastrointest Canc 50, 657–659 (2019). https://doi.org/10.1007/s12029-018-0098-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-018-0098-z